[Somatostatin analogues in the treatment of bleeding GI-angiodysplasias].
Angiodysplasias account for 2-8% of GI-bleeding episodes. We describe a 75-year-old patient with a history of anaemia for 1 year before being diagnosed with multiple angiodysplasias in the GI-tract. The patient needed weekly blood transfusions until he started treatment with octreotide. After 4 months of treatment the need for transfusions had decreased dramatically and faeces was negative for blood. Treatment was switched to long-acting octreotide (Sandostatin Lar). The case illustrates the usefulness of somatostatin analogues in the treatment of bleeding GI-angiodysplasias.
Boesby
Lene
L
Traneholmen 16B, DK-3460 Birkerød. lene@boesby.dk.
Christensen
Niels Juel
NJ
Kristensen
Lars Ostergaard
LO
D000368:Aged; D000740:Anemia / Q000209:etiology; D016888:Angiodysplasia / Q000150:complications*; D001803:Blood Transfusion; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000150:complications / Q000209:etiology*; D006801:Humans; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*
D005765:Gastrointestinal Agents; D015282:Octreotide